Label: SQUALANE PLUS MINERAL SPF 45- titanium dioxide and zinc oxide cream
-
Contains inactivated NDC Code(s)
NDC Code(s): 73517-123-01 - Packager: Amyris, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated February 25, 2020
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active Ingredients
- Purpose
-
Uses
- Helps prevent sunburn
- If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer & early signs of aging caused by the sun.
- Warnings
-
Directions
- Apply liberally and evenly to face and neck 15 minutes before sun exposure. Reapply:
- After 80 minutes of swimming or sweating. Immediately after towel drying.
- At least every 2 hours.
-
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum value of SPF 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10 a.m. – 2 p.m.
- Wear long-sleeved shirts, pants, hats, and sunglasses
- Children under 6 months of age: Ask a doctor.
- Apply liberally and evenly to face and neck 15 minutes before sun exposure. Reapply:
-
Inactive ingredients
Water, Caprylic/Capric Triglyceride, Squalane, Polyglyceryl-3 Sorbityl Linseedate, Cetyl Dimethicone, Dimethicone, Polymethylsilsesquioxane, Glycerin, Styrene/Acrylates Copolymer, Thermus Thermophilus Ferment, Polyhydroxystearic Acid, Synthetic Fluorphlogopite, Sodium Chloride, Hydroxyacetophenone, Tocopheryl Acetate, Saccharide Isomerate, Caramel, Pentylene Glycol, 1,2-Hexanediol, Caprylyl Glycol, Disteardimonium Hectorite, Triethoxycaprylylsilane, Bisabolol, Benzylidene Dimethoxydimethylindanone, Citrus Aurantium Amara (Bitter Orange) Flower Extract, Zingiber Officinale (Ginger) Root Extract
- Other Information
- Questions or Comments?
- PRINCIPAL DISPLAY PANEL - 50 ML Tube Carton
-
INGREDIENTS AND APPEARANCE
SQUALANE PLUS MINERAL SPF 45
titanium dioxide and zinc oxide creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:73517-123 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 40.69 mg in 1 mL Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 70 mg in 1 mL Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Medium-Chain Triglycerides (UNII: C9H2L21V7U) Squalane (UNII: GW89575KF9) Dimethicone (UNII: 92RU3N3Y1O) Polymethylsilsesquioxane (4.5 Microns) (UNII: 59Z907ZB69) Glycerin (UNII: PDC6A3C0OX) STYRENE/ACRYLAMIDE COPOLYMER (500000 MW) (UNII: 5Z4DPO246A) Thermus Thermophilus Lysate (UNII: 775R692494) POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F) Sodium Chloride (UNII: 451W47IQ8X) Hydroxyacetophenone (UNII: G1L3HT4CMH) .Alpha.-Tocopherol Acetate (UNII: 9E8X80D2L0) Saccharide Isomerate (UNII: W8K377W98I) Caramel (UNII: T9D99G2B1R) Pentylene Glycol (UNII: 50C1307PZG) 1,2-Hexanediol (UNII: TR046Y3K1G) Caprylyl Glycol (UNII: 00YIU5438U) Disteardimonium Hectorite (UNII: X687XDK09L) Triethoxycaprylylsilane (UNII: LDC331P08E) Levomenol (UNII: 24WE03BX2T) Benzylidene Dimethoxydimethylindanone (UNII: 75HIF3C97L) Citrus Aurantium Flower (UNII: O730ZX2Z83) Ginger (UNII: C5529G5JPQ) Product Characteristics Color WHITE Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:73517-123-01 1 in 1 CARTON 03/01/2018 1 50 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 03/01/2018 Labeler - Amyris, Inc. (185930182)